InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by DiRaimondo Thomas, Chief Scientific Officer. Insider active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 4 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €237k. History available since 27 September 2024. The latest transaction was disclosed on 2 January 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
2,505 shares@ US$13.7350.0% of flowCommon StockSEC:0002005618-26-000002
2,505 shares@ US$13.730.0035% mcap50.0% of flowCommon StockSEC:0002005618-26-000002:0
24,000 shares0Common StockSEC:0001415889-25-000673:0
4,325 shares@ US$46.205775.3% of flowCommon StockSEC:0001415889-24-024076:0
4 of 4 declarations
About DiRaimondo Thomas
Thomas DiRaimondo is the Chief Scientific Officer at Janux Therapeutics, Inc. He oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Janux.
